Evidence map›Paper›PMID 37790113›Full record

ArticleIranian journal of veterinary research2023

Gamma-oryzanol dose optimization in maturation or culture media for

S Musapoor, N Davoodian, A Kadivar, E Ahmadi, H Nazari, H Mehrban

Open access · greenAbstract read
In one paragraph

Article in Iranian journal of veterinary research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
0.9field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 3 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

S MusapoorPh.D. Student in Biotechnology of Animal Reproduction, Research Institute of Animal Embryo Technology, Shahrekord University, Shahrekord, Iran.
N DavoodianResearch Institute of Animal Embryo Technology, Shahrekord University, Shahrekord, Iran.
A KadivarResearch Institute of Animal Embryo Technology, Shahrekord University, Shahrekord, Iran.
E AhmadiResearch Institute of Animal Embryo Technology, Shahrekord University, Shahrekord, Iran.
H NazariResearch Institute of Animal Embryo Technology, Shahrekord University, Shahrekord, Iran.
H MehrbanDepartment of Animal Science, Faculty of Agriculture, Shahrekord University, Shahrekord, Iran, and Animal Science Research Institute of Iran, Agriculture Research, Education, and Extension Organization (AREEO), Karaj, Iran.
Shahrekord University · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Abstract. Background: The efficiency of ovine Aims: The present study evaluated the effect of different concentrations of gamma (γ)-oryzanol in maturation or culture media on Methods: Morphologically normal COCs were aspirated from ovine ovaries, subjected to maturation media supplemented with 0, 2.5, 5, 10, 20, 50, and 100 μM γ-oryzanol, then processed for conventional Results: The expansion of cumulus cover and survival rate tended to decrease with concentrations of 20, 50, and 100 μM in maturation media, suggesting an overdose effect. The cleavage and total blastocyst rates were significantly higher for oocytes matured at 5 μM γ-oryzanol. The presumptive zygotes cultured in supplemented media showed significantly higher cleavage and total blastocyst rates with concentrations of 5 and 10 μM γ-oryzanol (P<0.04) in both 7% and 20% O Conclusion: These results represent the first study showing a significant positive effect of the γ-oryzanol supplement on

Indexed as

AntioxidantEmbryonic developmentGamma-oryzanolSheep

Identifiers

PMID37790113
PMCPMC10542876
OpenAlexW4387325922

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.